Department of Neurology, Medical University of Wroclaw, Borowska 213, 50-556, Wroclaw, Poland.
Neurol Sci. 2013 Aug;34(8):1291-6. doi: 10.1007/s10072-012-1229-0. Epub 2012 Oct 30.
Sleep disturbances constitute one of the important yet underestimated aspects of functioning of patients with multiple sclerosis (MS). The objective of this study was to evaluate sleep disturbances in patients with MS, with regard to demographic factors, disease-related variables, co-existing conditions and fatigue. In 100 MS patients, Epworth Sleepiness Scale (ESS) and a questionnaire about sleep disturbances (SlD) were implemented. ESS and SlD results were analyzed with regard to age, gender, duration of MS, type of its course, degree of disability in Expanded Disability Status Scale (EDSS), MS therapies, coexisting diseases, results of Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS). ESS score indicated increased daytime sleepiness in 19 patients. In SlD, 49 subjects reported sleep disturbances and 35 more than one of their kind (most commonly terminal and middle insomnia). No relationships were found between ESS and SlD scores and age, gender, MS duration, type of its course, EDSS or coexisting diseases. In 36 patients, somatic complaints interfered with sleep. The patients with depression had significantly lower ESS result and those currently treated with immunomodulation had significantly lower SlD score. SlD score correlated positively with FSS and MFIS. Sleep disturbances in MS patients may occur independently from demographic and disease-related variables, but they are often influenced by the symptoms of MS and therapies used. Sleep disturbances may contribute to fatigue in the course of MS.
睡眠障碍是多发性硬化症(MS)患者功能障碍的一个重要但被低估的方面。本研究旨在评估 MS 患者的睡眠障碍,包括人口统计学因素、与疾病相关的变量、并存疾病和疲劳。对 100 名 MS 患者进行了 Epworth 嗜睡量表(ESS)和睡眠障碍问卷(SlD)的评估。分析了 ESS 和 SlD 的结果,包括年龄、性别、MS 病程、疾病类型、扩展残疾状况量表(EDSS)的残疾程度、MS 治疗、并存疾病、疲劳严重程度量表(FSS)和改良疲劳影响量表(MFIS)的结果。ESS 评分显示 19 名患者存在日间嗜睡。在 SlD 中,49 名患者报告存在睡眠障碍,其中 35 名患者存在不止一种睡眠障碍(最常见的是终末期和中段失眠)。ESS 和 SlD 评分与年龄、性别、MS 病程、疾病类型、EDSS 或并存疾病之间没有相关性。在 36 名患者中,躯体症状干扰了睡眠。患有抑郁症的患者 ESS 评分明显较低,而目前接受免疫调节治疗的患者 SlD 评分明显较低。SlD 评分与 FSS 和 MFIS 呈正相关。MS 患者的睡眠障碍可能与人口统计学和疾病相关的因素无关,但常常受到 MS 症状和所使用的治疗方法的影响。睡眠障碍可能导致 MS 病程中的疲劳。